PUBLISHER: Grand View Research | PRODUCT CODE: 1790287
PUBLISHER: Grand View Research | PRODUCT CODE: 1790287
Breast Prosthetic Market Summary
The global breast prosthetic market size was estimated at USD 360.0 million in 2024 and is projected to reach USD 692.7 million by 2033, growing at a CAGR of 7.60% from 2025 to 2033. The industry is experiencing significant growth driven by various factors. The rising prevalence of breast cancer worldwide is a primary catalyst, as increased incidences lead to a higher demand for reconstructive solutions.
The market has been experiencing notable growth driven by medical, technological, and social factors. One of the primary drivers is the increasing global incidence of breast cancer and patients undergoing mastectomy procedures. For instance, according to the American Society of Plastic Surgeons report published in November 2024, the proportion of patients choosing breast reconstruction following mastectomy has stabilized in recent years. Further, according to the same source, most patients receiving breast reconstruction had private insurance; however, this percentage declined from 85.0% to 75.1%. Conversely, the share of breast reconstruction patients covered by public health insurance has grown, with Medicaid patients increasing from 3.3% to 6.6% and Medicare patients rising from 9.9% to 15.6%. This suggests that increasing public health insurance for breast reconstruction is fueling the market growth.
According to the Breast Cancer Research Foundation, breast cancer is the most prevalent cancer among women globally, affecting both developed and developing countries. In 2022, approximately 2.3 million women were diagnosed with breast cancer worldwide, resulting in around 670,000 deaths. Alarmingly, every 14 seconds, a woman somewhere in the world receives a breast cancer diagnosis. Hence, a growing number of breast cancer cases is expected to boost the market demand.
As more women undergo mastectomy procedures, either as part of cancer treatment or prophylactically, the demand for breast prostheses rises. Additionally, growing awareness surrounding post-mastectomy reconstruction options-both surgical and non-surgical-has increased patient interest in breast prosthetics as a viable alternative or complement to reconstructive surgery. One of the leading breast reconstruction awareness campaigns is sponsored by the American Society of Plastic Surgeons (ASPS) and The Plastic Surgery Foundation (The PSF), with funding provided by corporations, institutions, private practices, and individuals. Many women, particularly older individuals or those with co-morbidities, opt for external prostheses due to the less invasive nature and quicker recovery time compared to reconstructive procedures.
Another significant driver is the psychological benefit associated with breast prosthetics. These devices help restore body image, self-esteem, and a sense of normalcy, which are often deeply impacted after a mastectomy. Moreover, the role of healthcare policies and reimbursement schemes cannot be overstated. In countries like the U.S., the Women's Health and Cancer Rights Act (WHCRA), Centers for Medicare & Medicaid Services (CMS) mandates insurance coverage for post-mastectomy prosthetic devices. In contrast, national health systems in Canada and several European countries offer subsidies or full coverage, removing financial barriers and broadening access.
Global Breast Prosthetic Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global breast prosthetic market report on the basis of product, application, distribution channel, and region: